SCHEMBL29270701

SCHEMBL29270701

Cc1cc2c(cc1-c1nnc(C(C)(C)C)o1)N(Cc1ccc(Cl)cc1)C(=O)[C@@H](CC(C)(C)NC(=O)O)CS2

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29270765 0.94 TP53 (0.30) —
SCHEMBL29270805 0.94 CNR2 (0.34) CNR2
SCHEMBL29270777 0.94 CLK1 (0.33) CNR2
SCHEMBL29270721 0.93 CNR2 (0.32) CNR2
SCHEMBL29270844 0.93 CNR2 (0.32) CNR2
SCHEMBL29270727 0.86 CNR2 (0.32) CNR2
SCHEMBL29270806 0.84 MDM2 (0.32) —
SCHEMBL29270734 0.84 TP53 (0.31) —
SCHEMBL29796919 0.82 POLB (0.36) CNR2
SCHEMBL26962249 0.82 POLB (0.36) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116964048-A Bicyclic tetrahydroazepine derivatives for the treatment of cancer 豪夫迈·罗氏有限公司 2023-10-27 — — CN disclosed
Send feedback